Employee Benefits as a Cultural and Valuation Advantage
In the second half of this Cascade Conversations episode, Unlocking Benefit Advantage, Eric Green, Cascade Managing Director and Jason Glime, Spartan Wealth Management President, focus on the cultural and qualitative impact of employee benefits and how proactive education strengthens both workforce engagement and M&A readiness. They emphasize that most employees do not fully understand their benefits, which can lead to frustration and misperceptions—even when plans are strong.
Jason explains how ongoing education, transparency around healthcare costs, and concierge-style support help employees become better consumers of healthcare, reinforcing a culture of care and trust. From a transaction perspective, they stress the importance of addressing benefits 12–18 months ahead of a sale to reduce costs, mitigate diligence risk, and enhance valuation through EBITDA improvement. The discussion concludes by highlighting the value of early collaboration between benefits advisors and investment bankers to identify red flags, create actionable checklists, and position companies more competitively for a sale.
Cascade Conversation Summary
Eric Green and Jason Glime explore employee healthcare benefits through a distinctly sell-side M&A lens, positioning benefits strategy as both a cultural signal and a material value driver in transactions.
The discussion begins with the qualitative impact of employee benefits on workforce perception, but quickly ties this to buyer scrutiny. Jason highlights a core risk area in M&A diligence: While many companies offer competitive benefit plans, most employees do not understand how those plans work. This lack of understanding often surfaces during diligence in the form of employee dissatisfaction, unexplained cost variability, and opaque healthcare spend—raising concerns for buyers about future cost escalation and cultural stability post-close.
Jason explains that proactive employee education and transparency around healthcare costs materially change this narrative. When employees are trained to select appropriate plans, understand deductibles and out-of-pocket expenses, and compare providers based on cost and quality, healthcare spending becomes more predictable and defensible. From an M&A perspective, this demonstrates disciplined management of one of the largest non-payroll P&L (Profit & Loss) expenses and reduces perceived integration risk.
A key focus of the conversation is timing. Jason advises companies to begin benefits analysis and optimization 12–18 months ahead of a sale process, allowing sufficient runway to identify inefficiencies, correct above-benchmark costs, and establish a documented strategy. Buyers value evidence that healthcare costs are actively managed rather than reactively renewed, particularly when evaluating normalized EBITDA and sustainability of cash flows.
Jason reinforces the valuation impact with a concrete example: A client operating approximately 18% above benchmark reduced healthcare costs by $100,000 annually. At a 5x multiple, that improvement translated into roughly $500,000 of incremental enterprise value—illustrating how benefits optimization can create disproportionate upside in a transaction.
The episode also underscores how benefits advisors can integrate seamlessly with investment bankers. Jason positions Spartan Benefit Advisors as an extension of the deal team—conducting early-stage employee benefits diligence, identifying red flags buyers are likely to uncover, and preparing actionable recommendations without burdening management. This approach strengthens the sell-side story, mitigates diligence friction, and supports a smoother transaction process.
The Takeaway on Employee Benefits and M&A
The conversation concludes with a broader M&A takeaway: Companies that proactively manage employee benefits signal operational maturity, cultural stewardship, and financial discipline. In a competitive deal environment, that combination can enhance valuation, reduce buyer concerns, and improve overall deal outcomes.